ClinicalTrials.Veeva

Menu

FungiScope - A Global Emerging Fungal Infection Registry

U

University of Cologne

Status

Enrolling

Conditions

Invasive Fungal Disease

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT01731353
Fungi001

Details and patient eligibility

About

The objective of this registry is to broaden the knowledge on epidemiology, diagnostic procedures and clinical course of emerging invasive fungal infections.

Full description

The specific objectives are:

  1. To determine the fungal species causing invasive fungal infection in different parts of the world.
  2. To determine the clinical pattern of disease and document procedures performed for confirmation of the diagnosis.
  3. To describe the therapeutic regimens used and their efficacy.
  4. To share clinical isolates among the contributors of Fungiscope.
  5. To develop molecular biology tools for identification of strains in histopathologically proven invasive fungal infection.

Enrollment

1,000 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Cultural, histopathological, antigen or DNA evidence of invasive fungal infection

Exclusion criteria

  • Infection due to Candida spp., Cryptococcus neoformans, Pneumocystis jiroveci
  • Endemic fungal infection such as coccidioidomycosis or histoplasmosis
  • Colonisation or other non-invasive infection

Trial design

1,000 participants in 1 patient group

Emerging fungal infections
Description:
Web-based registry of invasive infections by emerging fungi

Trial contacts and locations

1

Loading...

Central trial contact

Oliver A Cornely, Prof.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems